| CXHL1900064 | DDO-3055 | DDO-3055 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2019-02-01 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-01-31 | view |
| CXHL1900065 | DDO-3055片 | DDO-3055 | Tablet | Chemical Drugs(1) | New Drug Application | 2019-02-01 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-01-31 | view |
| CXHB2100045 | DDO-3055片 | DDO-3055 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-03-23 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2021-03-22 | view |
| CXHL1900066 | DDO-3055片 | DDO-3055 | Tablet | Chemical Drugs(1) | New Drug Application | 2019-02-01 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-01-31 | view |
| CXHL1300203 | HAO472 | HAO472 | Other | Chemical Drugs(1.1) | New Drug Application | 2013-05-02 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2013-10-17 | view |
| CXSB2101068 | HR011408注射液 | HR-011408 | Injection | Biological Products(2.1) | Supplementary Application | 2021-12-28 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXSL2101205 | HR011408注射液 | HR-011408 | Injection | Biological Products(2.1) | New Drug Application | 2021-07-20 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXSB2200066 | HR011408注射液 | HR-011408 | Injection | Biological Products(2.1) | Supplementary Application | 2022-08-04 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXHL2000405 | HR021611 | HR-021611 | Active ingredient | Chemical Drugs(2.2) | New Drug Application | 2020-08-27 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-08-25 | view |
| CXHL2000404 | HR021611 | HR-021611 | Active ingredient | Chemical Drugs(2.2) | New Drug Application | 2020-08-27 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-08-25 | view |
| CXHB2200005 | HR091506片 | HR-091506 | Tablet | Chemical Drugs(2.2) | Supplementary Application | 2022-01-17 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXHB2100030 | HR091506片 | HR-091506 | Tablet | Chemical Drugs(2.2) | Supplementary Application | 2021-02-24 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2021-02-23 | view |
| CXHL2000401 | HR091506片 | HR-091506 | Tablet | Chemical Drugs(2.2) | New Drug Application | 2020-08-27 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-08-25 | view |
| CXHB2100029 | HR091506片 | HR-091506 | Tablet | Chemical Drugs(2.2) | Supplementary Application | 2021-02-24 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2021-02-23 | view |
| CXHL2000400 | HR091506片 | HR-091506 | Tablet | Chemical Drugs(2.2) | New Drug Application | 2020-08-27 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-08-25 | view |
| CXHB2200006 | HR091506片 | HR-091506 | Tablet | Chemical Drugs(2.2) | Supplementary Application | 2022-01-17 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXSB2200012 | HR17031注射液 | HR-17031 | Injection | Biological Products(1) | Supplementary Application | 2022-01-26 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXSL2101090 | HR17031注射液 | HR-17031 | Injection | Biological Products(1) | New Drug Application | 2021-05-20 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXSB2300060 | HR17031注射液 | HR-17031 | Injection | Biological Products(1) | Supplementary Application | 2023-06-08 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXHB2200045 | HR18042片 | HR-18042 | Tablet | Chemical Drugs(2.3) | Supplementary Application | 2022-03-24 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
